Aktie A2AMWL CURAEGIS TECHNOLOGIES, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen CurAegis Technologies, Inc.

Aktien

A2AMWL

US23127Q1022

CRGS

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Involuntary Petition Approved for CurAegis Technologies, Inc.
Involuntary Petition Filed Against CurAegis Technologies, Inc.
CURAEGIS TECHNOLOGIES, INC. : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Other Events (form 8-K)
CurAegis Announces Immediate Cessation of Operations
CURAEGIS TECHNOLOGIES, INC. : Change in Directors or Principal Officers (form 8-K)
CurAegis Technologies, Inc. Announces Resignation of Aaron Newman as Director
CURAEGIS TECHNOLOGIES, INC. : Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
CurAegis Technologies, Inc. announced that it has received $0.035 million in funding from Geneva Roth Remark Holdings, Inc.
CURAEGIS TECHNOLOGIES, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
CURAEGIS TECHNOLOGIES, INC. : Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
CurAegis Technologies, Inc. announced that it has received $0.43 million in funding from Geneva Roth Remark Holdings, Inc.
CurAegis Technologies, Inc. Announces Resignation of Phil Saunders as Director
CURAEGIS TECHNOLOGIES, INC. : Change in Directors or Principal Officers (form 8-K)
CURAEGIS TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Curaegis Technologies, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
CurAegis Technologies, Inc. Announces the Resignation of Lance Drummond as Director
CURAEGIS TECHNOLOGIES, INC. : Change in Directors or Principal Officers (form 8-K)
CURAEGIS TECHNOLOGIES, INC. : Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
CurAegis Technologies, Inc. announced that it has received $0.05 million in funding from Geneva Roth Remark Holdings, Inc.
CURAEGIS TECHNOLOGIES, INC. : Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2AMWL Aktie
  4. Nachrichten CurAegis Technologies, Inc.
  5. Andere Sprachen